Zhejiang Huahai Pharmaceutical

600521 · SSE

Public Market Listing

600521SSE

SSE primary exchange listing

Live quotes, historical charts, and market capitalization for Zhejiang Huahai Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Hypidone (YL-0919)No recent activity
Phase 2
Serotonin transporter/5-HT1A receptor/sigma-1 receptorSmall molecule
Major Depressive Disorder

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (3 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$1.3B$167M——report ↗
View 2 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2023-FY$1.2B———report ↗
2022-FY$1.2B———report ↗